Generics Industry Offers Substitution, Not Rebates, As Health Reform Savings Proposal
This article was originally published in The Pink Sheet Daily
Executive Summary
Giving states incentives to boost Medicaid's use of generic drugs would produce more savings than Sen. Baucus' rebate proposals, Teva argues.